January 15, 2008 – On March 7 and 8, Yale School of Medicine and Nevada Cancer Institute (NVCI) will hold the Second Annual John R. Murren Memorial Symposium: “Advances in Thoracic Oncology” at The Red Rock Conference Center in Las Vegas.
The Yale School of Medicine designates this educational activity for a maximum of 8.5 AMA PRA Category 1 Credits.
John Murren M.D. was among the founders of both The Yale Cancer Center Thoracic Oncology Program and Nevada Cancer Institute. In honor of his efforts, the Course Directors, Drs. Lynn Tanoue, Nicholas Vogelzang, Giuseppe Pizzorno, and Daniel M. Goodenberger have gathered 10 “of the most formidable minds in cancer research in the area of thoracic oncology” to provide evidence-based education to multidisciplinary clinicians involved in the screening, diagnosis and treatment of patients with lung cancer and abnormal scans of the chest.
Participants who attend will be able to:
- Report on the current state of lung cancer care
- Review innovations in minimally invasive thoracic surgery and bronchoscopy
- Apply new advances in imaging for small pulmonary nodules
- Identify novel approaches to radiotherapy for lung cancer
- Assess updates in mesothelioma
- Engage in pathologic evaluation of bronchoalveolar carcinoma
- Discuss molecular pharmacology in lung cancer
- Understand and apply novel and targeted therapies for lung cancer
- Integrate evidence-based guidelines for lung cancer staging and
- Analyze current strategies of prevention and therapy
For more information: www.cme.yale.edu